Screening for Colorectal Cancer

Davis N C Mewland R C Terminology and classification of colorectal adenocarcinoma: The Australian clinico-pathological staging system. Aust NZ Surg 1983;53: 211–221.

CRC (Cancer Research Campaign). Facts on Cancer. Factsheet 18.1. London: Cancer Research Campaign, 1993.

Groden J Thliveris A Samowitz W Identification and characterization of the familial adenomatous polyposis locus. Cell 1991;66: 600–613.

Bussey H J R Familial polyposis coli: family studies, histopathology, differential diagnosis and results of treatment. Baltimore: Johns Hopkins University Press, 1975.

Vasen H F Mecklin J P Khan P Meera Lynch H . The International collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34: 424–425.

Vasen H F Wijnen J T Menko F H Cancer risk in families with hereditary non-polyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110: 1020–1027.

Lynch H T Smyrk T C Watson P Genetics, natural history, tumour spectrum and pathology of hereditary non-polyposis colorectal cancer: An updated review. Gastroenterology 1993;104: 1535–1549.

Spigelmau A D Williams C B Talbot I C Domizio P Phillips R K S Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2: 783–785.

Vasen H F Nagengast F M Khan P Meera . Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995;345: 1183–1184.

Lovett E . Family studies in cancers of the colon and rectum. British Journal of Surgery 1976;63: 13–18.

Houlston R S Murday V Harocopos C Williams C B Slack J . Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. British Medical Journal 1990;301: 366–368.

Carpenter S Broughton M Marks C G A screening clinic for relatives of patients with colorectal cancer in a district general hospital. Gut 1995;36: 90–92.

Cali R L Pitsch R M Thorson A G Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993;36: 388–393.

RCS (Royal College of Surgeons of England) and Association of Coloproctology. Guidelines on the Management of Colorectal Cancer. London: Royal College of Surgeons of England, 1996.

Juhl G Larson G M Mullins R Bond S Polk H C Six-year results of annual colonoscopy after resection of colorectal cancer. World Journal of Surgery 1990;14: 255–261.

Winawer S J Zauber A G Ho M N Prevention of colorectal cancer by colonoscopic polypectomy. New England Journal of Medicine 1993;329: 1977–1981.

Collins R H Feldman M Fordtran J S Colon cancer, dysplasia and surveillance in patients with ulcerative colitis: A critical review. New England Journal of Medicine 1987;316: 1654–1658.

Choi P M Zelig M P Similarity of colorectal cancer in Crohn's disease and ulcerative colitis; implications for carcinogenesis and prevention. Gut 1994;35: 950–954.

Lynch D A F Lobo A J Sobala G M Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34: 1075–1080.

Sachar D B Clinical and colonoscopic surveillance in ulcerative colitis: Are we saving colons or saving lives? Gastroenterology 1993;105: 588–589.

Kronborg O Fenger C Sondergaard O Pederson K M Olsen J . Initial mass screening for colorectal cancer with fecal occult blood test. Scandinavian Journal of Gastroenterology 1987;22: 677–686.

Thomas W M Pye G Hardcastle J D Walker A R Screening for colorectal cancer: An analysis of the sensitivity of Haemoccult. British Journal of Surgery 1992;79: 833–835.

Robinson M H E Thomas W M Pye G Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia? European Journal of Surgical Oncology 1993;19: 539–542.

Mandel J S Bond J H Church J R Reducing mortality from colorectal cancer by screening for faecal occult blood. New England Journal of Medicine 1993;328: 1365–1371.

Hardcastle J D Chamberlain J O Robinson M H E Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348: 1472–1477.

Robinson M H E Thomas W M Hardcastle J D Chamberlain J Mangham C M Change towards earlier stage at presentation of colorectal cancer. British Journal of Surgery 1993;80: 1610–1612.

Kronborg O Fenger C Olsen J Jorgensen O D Sondergaard O . Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348: 1467–1471.

Kewenter J Brevinge H Engaras B Haglind E Ahren C . Results of screening, rescreening, and follow-up in a prospective randomised study for detection of colorectal cancer by faecal occult blood testing, results for 68,308 subjects. Scandinavian Journal of Gastroenterology 1994;29: 468–473.

Budenholzer B . Screening for colorectal cancer. British Medical Journal 1997;349: 356–357.

Lijimer J G Bossuyt P M M Screening for colorectal cancer. British Medical Journal 1997;349: 357.

Hardcastle J D Screening for colorectal cancer. British Medical Journal 1997;349: 358.

Bhattacharya I Sack E M Screening colonoscopy: The cost of common sense. Lancet 1996;347: 1774–1775.

Read T E Read J D Butterly L F Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. New England Journal of Medicine 1997;336: 8–12.

Selby J V Friedman G D Quesenbery C P Weiss N S A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. New England Journal of Medicine 1992;326: 653–657.

Newcomb P A Norfleet R G Storer B E Surawicz T S Marcus P M Screening sigmoidoscopy and colorectal cancer mortality. Journal of the National Cancer Institute 1992;84: 1572–1575.

Shapiro S . Case-control studies of colorectal cancer mortality: Is the case made for screening sigmoidoscopy? Journal of the National Cancer Institute 1992;84: 1546–1547.

Bennet D H Hardcastle J D Early diagnosis and screening. In: Williams N , ed. Colorectal cancer. Clinical Surgery International 1993;Vol 20: 21–37.

Bond J H Polyp guideline: Diagnosis, treatment and surveillance for patients with non-familial colorectal polyps. Annals of International Medicine 1993;119: 836–843.

Winawar S J Zauber A G O'Brien M J Randomised comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. New England Journal of Medicine 1993;328: 901–906.

Luchtefeld M A Syverson D Soltek M Is colonoscopic screening appropriate in asymptomatic patients with a family history of colon cancer? Dis Colon Rectum 1991;34: 763–768.

Cuckburn J Staples M Hurley S de Juise T . Psychological costs of screening mamography. Journal of Medical Screening 1994;1: 7–12.

Haynes R B Sackett D L Taylor D W Gibson E S Johnson A L Increased absenteeism from work after detection and labelling of hypertensive patients. New England Journal of Medicine 1978;299: 741–744.

Tymstra R Bielman U . The psychosocial impact of mass screening for disease. Family Practitioner 1987;4: 287–290.

Giardiello F M Brensinger J D Petersen G M The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New England Journal of Medicine 1997;336: 823–827.

Vasen H F A van der Luijt R B Slors J F M Buskens E de Ruiter P Baeten C G M Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348: 433–435.

Launoy G Veret J L Richir B Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France). European Journal of Cancer Prevention 1993;2: 229–232.

Hope R L Chu G Hope A H Newcombe R G Gillespie P E Williams S J Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Gut 1996;39: 722–725.

Sidransky D Tokino T Hamilton S R Identification of ras oncogene mutations in the stool of patients with curable colorectal tumours. Science 1992;256: 102–105.

Raven J Smith England J Talbot I C Bodmer W . Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 1995;36: 81–86.

Eguchi S Norihiro K Komuta K Kanematsu T . Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer 1996;77: 1707–1710.

Aitken W S Cuzick J Northover J M A Whynes D K Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993;341: 736–740.

Aitken W S McIntyre P Aubrey R Cuzick J Edwards R Northover J M A Pilot study for a multicentre randomised trial of ‘once only’ flexible sigmoidoscopy for prevention of bowel cancer. Gut 1996;38: A9.

Lieberman D A Sleisenger M H Is it time to recommend screening for colorectal cancer? Lancet 1996;348: 1463–1464.

Mella J Biffin A Radcliffe A G Stamatakis J D Steele R J C A population-based audit of colorectal cancer management in two United Kingdom health regions. British Journal of Surgery (in press).